Phase II study of gemcitabine and carboplatin in metastatic breast cancers with prior exposure to anthracyclines and taxanes

Author： Chan Daniel   Yeo Wee-Lee   Tiemsim Cordero Maricel   Wong Chiung-Ing   Chuah Benjamin   Soo Ross   Tan Sing-Huang   Lim Siew-Eng   Goh Boon-Cher   Lee Soo-Chin  

Publisher： Springer Publishing Company

ISSN： 0167-6997

Source： Investigational New Drugs, Vol.28, Iss.6, 2010-12, pp. : 859-865

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II study of gemcitabine in combination with vinorelbine versus gemcitabine followed by vinorelbine for metastatic breast cancer

By Park In   Ro Jungsil   Lee Keun   Kim Shi   Yun Young   Nam Byung  

Investigational New Drugs, Vol. 28, Iss. 5, 2010-10 ,pp. : 659-669

Springer Publishing Company

Access to resources Recommend Favorite

Gemcitabine and mitoxantrone in metastatic breast cancer: A phase-I-study

By Schmid Peter   Flath Bernd   Akrivakis Konstantin   Heilmann Volker   Mergenthaler Hans-Günther   Sezer Orhan   Kreienberg Rolf   Possinger Kurt  

Investigational New Drugs, Vol. 23, Iss. 4, 2005-08 ,pp. : 349-356

Springer Publishing Company

Access to resources Recommend Favorite

Gemcitabine plus enzastaurin or single-agent gemcitabine in locally advanced or metastatic pancreatic cancer: Results of a Phase II, randomized, noncomparative study

By Richards Donald   Kuefler Paul   Becerra Carlos   Wilfong Lalan   Gersh Robert   Boehm Kristi   Zhan Feng   Asmar Lina   Myrand Scott   Hozak Rebecca   Zhao Luping   Gill John   Mullaney Brian   Obasaju Coleman   Nicol Steven  

Investigational New Drugs, Vol. 29, Iss. 1, 2011-02 ,pp. : 144-153

Springer Publishing Company

Access to resources Recommend Favorite

A phase II randomized study of cetuximab and bevacizumab alone or in combination with gemcitabine as first-line therapy for metastatic pancreatic adenocarcinoma

By Ko Andrew  

Investigational New Drugs, Vol. 30, Iss. 4, 2012-08 ,pp. : 1597-1606

Springer Publishing Company

Access to resources Recommend Favorite

BA11: Randomised Phase III Study Comparing Paclitaxel/Cisplatin/Gemcitabine and Cisplatin/Gemcitabine in Patients with Metastatic or Locally Advanced Urothelial Cancer without Prior Systemic Therapy*

By  

UroOncology, Vol. 2, Iss. 2, 2002-01 ,pp. : 55-56

Ashgate Publishing Ltd

Access to resources Recommend Favorite